These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7403407)

  • 1. A study of haloperidol in young autistic children: a within-subjects design using objective rating scales.
    Cohen IL; Campbell M; Posner D
    Psychopharmacol Bull; 1980 Jul; 16(3):63-5. PubMed ID: 7403407
    [No Abstract]   [Full Text] [Related]  

  • 2. Haloperidol in the treatment of infantile autism: effects on learning and behavioral symptoms.
    Anderson LT; Campbell M; Grega DM; Perry R; Small AM; Green WH
    Am J Psychiatry; 1984 Oct; 141(10):1195-202. PubMed ID: 6385731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of live and videotape ratings: clomipramine and haloperidol in autism.
    Sanchez LE; Adams PB; Uysal S; Hallin A; Campbell M; Small AM
    Psychopharmacol Bull; 1995; 31(2):371-8. PubMed ID: 7491394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial.
    Akhondzadeh S; Erfani S; Mohammadi MR; Tehrani-Doost M; Amini H; Gudarzi SS; Yasamy MT
    J Clin Pharm Ther; 2004 Apr; 29(2):145-50. PubMed ID: 15068403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scales for the assessment of neuroleptic response in schizophrenic children: specific measures derived from the CPRS.
    Spencer EK; Alpert M; Pouget ER
    Psychopharmacol Bull; 1994; 30(2):199-202. PubMed ID: 7831455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptic-related dyskinesias in autistic children: a prospective study.
    Perry R; Campbell M; Green WH; Small AM; Die Trill ML; Meiselas K; Golden RR; Deutsch SI
    Psychopharmacol Bull; 1985; 21(1):140-3. PubMed ID: 3885290
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma beta-endorphin levels, naltrexone, and haloperidol in autistic children.
    Ernst M; Devi L; Silva RR; Gonzalez NM; Small AM; Malone RP; Campbell M
    Psychopharmacol Bull; 1993; 29(2):221-7. PubMed ID: 8290669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of stereotypies from neuroleptic-related dyskinesias in autistic children.
    Meiselas KD; Spencer EK; Oberfield R; Peselow ED; Angrist B; Campbell M
    J Clin Psychopharmacol; 1989 Jun; 9(3):207-9. PubMed ID: 2500463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naltrexone in autistic children: behavioral symptoms and attentional learning.
    Campbell M; Anderson LT; Small AM; Adams P; Gonzalez NM; Ernst M
    J Am Acad Child Adolesc Psychiatry; 1993 Nov; 32(6):1283-91. PubMed ID: 8282676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of haloperidol, behavior therapy, and their interaction in autistic children [proceedings].
    Campbell M; Anderson LT; Meier M
    Psychopharmacol Bull; 1979 Apr; 15(2):84-6. PubMed ID: 373009
    [No Abstract]   [Full Text] [Related]  

  • 11. [Value of behavior scales and urinary homovanillic acid determinations in monitoring the combined treatment with vitamin B6 and magnesium of children displaying autistic behavior].
    Barthélémy C; Garreau B; Leddet I; Sauvage D; Muh JP; Lelord G; Callaway E
    Neuropsychiatr Enfance Adolesc; 1983; 31(5-6):289-301. PubMed ID: 6888687
    [No Abstract]   [Full Text] [Related]  

  • 12. Differential response of seven subjects with autistic disorder to clomipramine and desipramine.
    Gordon CT; Rapoport JL; Hamburger SD; State RC; Mannheim GB
    Am J Psychiatry; 1992 Mar; 149(3):363-6. PubMed ID: 1536276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind comparison of haloperidol (Haldol) and thioridazine (Mellaril) in outpatient children.
    Claghorn JL
    Curr Ther Res Clin Exp; 1972 Dec; 14(12):785-9. PubMed ID: 4629817
    [No Abstract]   [Full Text] [Related]  

  • 14. Short-term efficacy and safety of fenfluramine in hospitalized preschool-age autistic children: an open study.
    Campbell M; Deutsch SI; Perry R; Wolsky BB; Palij M
    Psychopharmacol Bull; 1986; 22(1):141-7. PubMed ID: 3726060
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of small doses of haloperidol on autistic children.
    Hoshino Y; Yashima Y; Ishige K; Kaneko M; Kumashiro H
    Fukushima J Med Sci; 1979; 26(1-2):43-54. PubMed ID: 521004
    [No Abstract]   [Full Text] [Related]  

  • 16. Clomipramine versus haloperidol in the treatment of autistic disorder: a double-blind, placebo-controlled, crossover study.
    Remington G; Sloman L; Konstantareas M; Parker K; Gow R
    J Clin Psychopharmacol; 2001 Aug; 21(4):440-4. PubMed ID: 11476129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study.
    Wasserman S; Iyengar R; Chaplin WF; Watner D; Waldoks SE; Anagnostou E; Soorya L; Hollander E
    Int Clin Psychopharmacol; 2006 Nov; 21(6):363-7. PubMed ID: 17012983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study.
    Amminger GP; Berger GE; Schäfer MR; Klier C; Friedrich MH; Feucht M
    Biol Psychiatry; 2007 Feb; 61(4):551-3. PubMed ID: 16920077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of haloperidol on learning and behavior in autistic children.
    Campbell M; Anderson LT; Small AM; Perry R; Green WH; Caplan R
    J Autism Dev Disord; 1982 Jun; 12(2):167-75. PubMed ID: 7174605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of drug effects in autistic children.
    Cohen IL; Anderson LT; Campbell M
    Psychopharmacol Bull; 1978 Oct; 14(4):68-70. PubMed ID: 704767
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.